Outset Medical Inc - Common Stock (OM)

CUSIP: 690145107

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
18,303,310
Total 13F shares
21,051,997
Share change
-5,028,294
Total reported value
$23,361,826
Put/Call ratio
122%
Price per share
$1.11
Number of holders
73
Value change
-$3,640,595
Number of buys
23
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 690145107?
CUSIP 690145107 identifies OM - Outset Medical Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OM - Outset Medical Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13D/G 13F
Company
7%
3,671,213
$21,334,153 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
14%
2,644,534
$1,790,349 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
10%
1,888,424
$1,278,463 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
9.9%
1,810,234
$1,225,529 30 Sep 2024
13F
Steven S. Williamson
3/4/5
Chief Commercial Officer
class O/S missing
320,347
$1,143,639 15 Feb 2024
GMT CAPITAL CORP
13F
Company
8%
1,471,706
$996,345 30 Sep 2024
13F
Mubadala Investment Co PJSC
13F
Company
7.9%
1,440,601
$975,287 30 Sep 2024
13F
Ensign Peak Advisors, Inc
13F
Company
7.6%
1,388,943
$940,315 30 Sep 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
7.1%
1,303,132
$881,000 30 Sep 2024
13F
Jean-Olivier Racine
3/4/5
Chief Technology Officer
class O/S missing
265,325
$867,613 10 May 2024
MORGAN STANLEY
13F
Company
6.5%
1,184,262
$801,746 30 Sep 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
6.1%
1,111,612
$753,000 30 Sep 2024
13F
C WorldWide Group Holding A/S
13F
Company
5.5%
1,000,000
$677,000 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
5%
910,787
$616,604 30 Sep 2024
13F
Martin Vazquez
3/4/5
Chief Operating Officer
mixed-class rows
146,619
mixed-class rows
$442,350 01 Mar 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
3.1%
568,971
$385,383 30 Sep 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
2.3%
428,636
$290,187 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
2.3%
417,477
$283,884 30 Sep 2024
13F
James F. Hinrichs.
3/4/5
Director
class O/S missing
80,349
$283,632 29 May 2024
TWO SIGMA ADVISERS, LP
13F
Company
2.2%
404,900
$274,117 30 Sep 2024
13F
Assenagon Asset Management S.A.
13F
Company
2.2%
397,619
$269,188 30 Sep 2024
13F
Stacey L. Porter
3/4/5
Chief People Officer
class O/S missing
61,448
$263,612 12 Jan 2024
BANK OF MONTREAL /CAN/
13F
Company
2.3%
420,550
$257,840 30 Sep 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
2%
359,268
$243,224 30 Sep 2024
13F
Dale E. Jones
3/4/5
Director
class O/S missing
45,918
$162,091 29 May 2024
STATE STREET CORP
13F
Company
1.1%
194,673
$131,794 30 Sep 2024
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.99%
180,444
$122,161 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.92%
168,656
$114,180 30 Sep 2024
13F
Catherine M. Szyman
3/4/5
Director
class O/S missing
24,596
$105,517 31 May 2023
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
13F
Company
0.66%
121,346
$82,000 30 Sep 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.55%
100,000
$67,700 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
0.54%
99,029
$67,340 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.54%
99,122
$67,106 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.5%
91,684
$62,070 30 Sep 2024
13F
Rebecca Chambers
3/4/5
Chief Financial Officer
mixed-class rows
91,342
mixed-class rows
$58,331 24 Jun 2021
MACKENZIE FINANCIAL CORP
13F
Company
0.46%
84,656
$57,312 30 Sep 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.46%
83,814
$56,742 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.38%
69,600
$48,000 30 Sep 2024
13F
HUNTINGTON NATIONAL BANK
13F
Company
0.35%
63,306
$42,858 30 Sep 2024
13F
Corient Private Wealth LLC
13F
Company
0.33%
61,149
$41,398 30 Sep 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.3%
55,245
$37,401 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.3%
54,174
$36,676 30 Sep 2024
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0.29%
52,407
$35,480 30 Sep 2024
13F
HighTower Advisors, LLC
13F
Company
0.26%
48,503
$33,000 30 Sep 2024
13F
Harbor Advisors LLC
13F
Company
0.25%
45,000
$30,465 30 Sep 2024
13F
GRIFFIN ASSET MANAGEMENT, INC.
13F
Company
0.23%
42,275
$28,620 30 Sep 2024
13F
LPL Financial LLC
13F
Company
0.22%
40,386
$27,341 30 Sep 2024
13F
360 Financial, Inc.
13F
Company
0.16%
28,710
$19,437 30 Sep 2024
13F
Aster Capital Management (DIFC) Ltd
13F
Company
0.15%
27,738
$18,779 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.15%
27,476
$18,601 30 Sep 2024
13F

Institutional Holders of Outset Medical Inc - Common Stock (OM) as of Q4 2024

As of 31 Dec 2024, Outset Medical Inc - Common Stock (OM) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,051,997 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, GMT CAPITAL CORP, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, Ensign Peak Advisors, Inc, ACADIAN ASSET MANAGEMENT LLC, C WorldWide Group Holding A/S, GSA CAPITAL PARTNERS LLP, and BlackRock, Inc.. This page lists 74 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
76
Q4 2024 holders
73
Holder diff
-3
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.